Coherus Biosciences Manages UDENYCA Supply Interruption and Cost Reductions
PremiumCompany AnnouncementsCoherus Biosciences Manages UDENYCA Supply Interruption and Cost Reductions
2M ago
Coherus Biosciences downgraded to Neutral from Buy at UBS
Premium
The Fly
Coherus Biosciences downgraded to Neutral from Buy at UBS
3M ago
Coherus Biosciences reports Q2 EPS (14c), consensus (29c)
Premium
The Fly
Coherus Biosciences reports Q2 EPS (14c), consensus (29c)
3M ago
Coherus Biosciences announces divestiture of YUSIMRY in $40M transaction
PremiumThe FlyCoherus Biosciences announces divestiture of YUSIMRY in $40M transaction
5M ago
Coherus Biosciences Appoints Rita Karachun to Board
Premium
Company Announcements
Coherus Biosciences Appoints Rita Karachun to Board
5M ago
Coherus Biosciences appoints Karachun to board of directors
Premium
The Fly
Coherus Biosciences appoints Karachun to board of directors
5M ago
Coherus Biosciences Embarks on Strategic Financial Restructuring
PremiumCompany AnnouncementsCoherus Biosciences Embarks on Strategic Financial Restructuring
6M ago
Coherus Biosciences announces clinical collaboration with CRI
Premium
The Fly
Coherus Biosciences announces clinical collaboration with CRI
6M ago
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100